Long-term efficacy and safety of sirolimus for retinal astrocytic hamartoma associated with tuberous sclerosis complex

Mammalian target of rapamycin (mTOR) inhibitors (sirolimus or everolimus) have been demonstrated effective in reducing the size of tuberous sclerosis complex (TSC)-associated retinal astrocytic hamartoma (RAH) in short term. To investigate the long-term efficacy and safety of sirolimus on TSC-associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chen-Xi, Xu, Kai-Feng, Long, Qin, Zhang, Xiao, Yang, Zhi-Kun, Dai, Rong-Ping, Zhang, Zhi-Qiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716018/
https://www.ncbi.nlm.nih.gov/pubmed/36467422
http://dx.doi.org/10.3389/fcell.2022.973845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716018/
https://www.ncbi.nlm.nih.gov/pubmed/36467422
http://dx.doi.org/10.3389/fcell.2022.973845

Ejemplares similares